NASDAQ:ARPO
Delisted
Aerpio Pharmaceuticals Inc. Stock News
$13.14
-0.370 (-2.74%)
At Close: Aug 17, 2022
Aerpio Pharmaceuticals to Report Year Ended December 31, 2019 Financial Results on Monday, March 16, 2020
09:00pm, Thursday, 12'th Mar 2020
CINCINNATI, March 12, 2020 -- Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular.
Those Who Purchased Aerpio Pharmaceuticals (NASDAQ:ARPO) Shares A Year Ago Have A 80% Loss To Show For It
02:49pm, Sunday, 09'th Feb 2020
While it may not be enough for some shareholders, we think it is good to see the Aerpio Pharmaceuticals, Inc...
Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, announced that Kevin Pe
Marketplace Authors' Picks For 2020
12:30pm, Monday, 06'th Jan 2020
For the final note of our year-end Marketplace Roundtable series, we compile all of our authors' named favorite ideas. The authors' focuses range from macro to
Hedge Funds Are Buying Aerpio Pharmaceuticals, Inc. (ARPO)
10:08pm, Sunday, 22'nd Dec 2019
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilitie
Here's Why We're A Bit Worried About Aerpio Pharmaceuticals's (NASDAQ:ARPO) Cash Burn Situation
11:59am, Monday, 11'th Nov 2019
We can readily understand why investors are attracted to unprofitable companies. For example, although...
How billionaire charter school funders corrupt education by making it like a business
09:51pm, Wednesday, 16'th Oct 2019
It’s rare when goings-on in Kansas City schools make national headlines, but in 2011 the New York Times reported on the sudden departure of the district’s superintendent John Covington, who resign
